Following a successful preview at the 2017 Respiratory Drug Delivery (RDD) Europe conference, Copley Scientific, the world’s leading manufacturer of inhaler test equipment, has launched its new 3rd generation Critical Flow Controller – the TPK™ 2100 – for the testing of dry powder inhalers (DPIs).

Read @ https://www.1888pressrelease.com/faster-more-reproducible-dry-powder-inhaler-testing-cople-pr-622765.html